Articles with public access mandates - Brona M. MurphyLearn more
OverallEuropean CommissionSFIHRBDFGIRCNIHSNSFUSEDVAHHMIAHAFWFINSERMOTKAHEATelethonVersus Arthritis, UKBBSRCBHFCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKParkinson's UKWellcomeWorldwide Cancer Research, UKDoris Duke Charitable FoundationANR
Not available anywhere: 3
Depletion of 14‐3‐3 zeta elicits endoplasmic reticulum stress and cell death, and increases vulnerability to kainate‐induced injury in mouse hippocampal cultures
N Murphy, HP Bonner, MW Ward, BM Murphy, JHM Prehn, DC Henshall
Journal of neurochemistry 106 (2), 978-988, 2008
Mandates: Higher Education Authority, Ireland
Targeting autophagy in glioblastoma
J Noonan, J Zarrer, BM Murphy
Critical Reviews™ in Oncogenesis 21 (3-4), 2016
Mandates: Health Research Board, Ireland
Ni (II), Pd (II), and Pt (II) Complexes of the Hedgehog Pathway Inhibitor GANT61-D
AL Ryan, MC Fitzgerald, A Ozsváth, B Twamley, P Buglyó, BM Murphy, ...
Inorganic Chemistry 58 (23), 16075-16086, 2019
Mandates: Hungarian Scientific Research Fund, Irish Research Council
Available somewhere: 23
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health, US …
Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway
CG Concannon, BF Koehler, C Reimertz, BM Murphy, C Bonner, ...
Oncogene 26 (12), 1681-1692, 2007
Mandates: German Research Foundation
Identification of a novel Bcl-2-interacting mediator of cell death (Bim) E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in rapid ischemic tolerance …
S Thompson, AN Pearson, MD Ashley, V Jessick, BM Murphy, P Gafken, ...
Journal of Biological Chemistry 286 (22), 19331-19339, 2011
Mandates: US National Institutes of Health
Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma
T Engel, BM Murphy, S Hatazaki, EM Jimenez-Mateos, CG Concannon, ...
The FASEB Journal 24 (3), 853, 2010
Mandates: Science Foundation Ireland
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach
ÁC Murphy, B Weyhenmeyer, J Schmid, SM Kilbride, M Rehm, HJ Huber, ...
Cell death & disease 4 (5), e629-e629, 2013
Mandates: Science Foundation Ireland
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
ÁC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride, S Schimansky, ...
Apoptosis 19, 629-642, 2014
Mandates: Science Foundation Ireland
Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus
BM Murphy, T Engel, A Paucard, S Hatazaki, G Mouri, K Tanaka, LP Tuffy, ...
Cell Death & Differentiation 17 (3), 459-468, 2010
Mandates: US National Institutes of Health, Science Foundation Ireland
New hints towards a precision medicine strategy for IDH wild-type glioblastoma
K White, K Connor, J Clerkin, BM Murphy, M Salvucci, AC O'Farrell, ...
Annals of Oncology 31 (12), 1679-1692, 2020
Mandates: National Institute of Health and Medical Research, France, European …
Cyclin-dependent kinase inhibitors in brain cancer: Current state and future directions
V Juric, B Murphy
Cancer Drug Resistance 3 (1), 48, 2020
Mandates: European Commission
Platinum (IV) oxaliplatin–peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells
AM McKeon, J Noonan, M Devocelle, BM Murphy, DM Griffith
Chemical Communications 53 (82), 11318-11321, 2017
Mandates: Science Foundation Ireland
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
C Boccellato, E Kolbe, N Peters, V Juric, G Fullstone, M Verreault, ...
Cell death & disease 12 (7), 647, 2021
Mandates: German Research Foundation, European Commission
Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP-and Bcl-2 antagonism
FA Lincoln, D Imig, C Boccellato, V Juric, J Noonan, RE Kontermann, ...
Cell death & disease 9 (11), 1112, 2018
Mandates: German Research Foundation, Health Research Board, Ireland, European …
Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide
BC Weyhenmeyer, J Noonan, ML Würstle, FA Lincoln, G Johnston, ...
Oncotarget 7 (38), 61295, 2016
Mandates: Health Research Board, Ireland, European Commission
System-based approaches as prognostic tools for glioblastoma
M Salvucci, Z Zakaria, S Carberry, A Tivnan, V Seifert, D Kögel, ...
BMC cancer 19, 1-17, 2019
Mandates: Science Foundation Ireland, European Commission
Synthesis and characterisation of a novel mono functionalisable Pt (IV) oxaliplatin-type complex and its peptide conjugate
E Kitteringham, AM McKeon, P O'Dowd, M Devocelle, BM Murphy, ...
Inorganica Chimica Acta 505, 119492, 2020
Mandates: Science Foundation Ireland
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
JJ Noonan, M Jarzabek, FA Lincoln, BL Cavanagh, AR Pariag, V Juric, ...
Cancers 11 (12), 2005, 2019
Mandates: Health Research Board, Ireland, European Commission
Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation
V Juric, L Hudson, J Fay, CE Richards, H Jahns, M Verreault, F Bielle, ...
Cell Death & Disease 12 (8), 763, 2021
Mandates: German Research Foundation, Health Research Board, Ireland, Science …
Publication and funding information is determined automatically by a computer program